BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Chinese Patent Office
Daiichi Sankyo
Baxter
Novartis
Argus Health
Express Scripts
UBS
Johnson and Johnson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078571

« Back to Dashboard

NDA 078571 describes MOMETASONE FUROATE, which is a drug marketed by Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Perrigo Israel, Perrigo New York, Amneal Pharms, and Apotex Inc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the MOMETASONE FUROATE profile page.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 078571
Tradename:MOMETASONE FUROATE
Applicant:Glenmark Generics
Ingredient:mometasone furoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 078571
Medical Subject Heading (MeSH) Categories for 078571
Suppliers and Packaging for NDA: 078571
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 078571 ANDA Glenmark Pharmaceuticals Inc., USA 68462-225 68462-225-17 15 g in 1 TUBE (68462-225-17)
MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 078571 ANDA Glenmark Pharmaceuticals Inc., USA 68462-225 68462-225-55 45 g in 1 TUBE (68462-225-55)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:May 28, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Boehringer Ingelheim
Express Scripts
Mallinckrodt
McKinsey
Healthtrust
Julphar
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot